Caribou Biosciences, Inc. (CRBU) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Since a ch ...

Skye, headquartered in San Diego, is a clinical-stage biotechnology company developing treatments for obesity and metabolic diseases. The complaint alleges that, throughout the Class Period, Defendants misled investors as to the prospects of its lead candidate, nimacimab. Investors allegedly learned the truth on October 6, 2025, when Skye published topline findings from its 26- week Phase 2a CBeyond trial of nimacimab, revealing that it failed to meet its primary weight-loss endpoint versus placebo. On this ...

Ionis Pharmaceuticals (NasdaqGS:IONS) FY Conference January 13, 2026 11:15 AM ET Company ParticipantsBrett Monia - CEOConference Call ParticipantsJessica Fye - AnalystJessica Fye Great. Good morning, everyone. Welcome. My name's Jessica Fye, Large Cap Biotech Analyst at J.P. Morgan, and we're continuing the 44th Annual Healthcare Conference this morning with Ionis. You're going to hear a presentation from the management team, and then we're going to go into some Q&A. So if you have any questions in the room ...

BREAKING: Core CPI Inflation Unexpectedly Holds At Low 2.6% Today's Spotlight As the Dow Jones Industrial Average and other stock indexes move mixed during Tuesday's session, Amazon (AMZN), Idexx Laboratories (IDXX), SharkNinja (SN), and Eli Lilly (LLY) are among the best names to watch in the current market. With key indexes at or near their all-time highs, investors using Investor's Business Daily's IBD Methodology await breakouts. It's also important to raise and… Related news Nvidia Partners With Biotec ...

Biotech stock Travere Therapeutics Inc (NASDAQ:TVTX) is plummeting today, down 32.8% to trade at $22.92 at last glance, after news that the Food & Drug Administration (FDA) has new questions regarding its Filspari application, which could cause a potential delay for the serious kidney disease treatment. The market is brushing off the company's strong fourth-quarter sales, which closed out "an exceptional year of commercial execution with Filspari," per President and CEO Eric Dube, Ph. D.Should these losses ...

New U.S. intellectual property protections expand use of Minovia’s leading technology in mitochondrial-based therapies for primary mitochondrial and severe renal diseasesHAIFA, Israel, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Minovia Therapeutics Ltd. (“Minovia” or the “Company”), a clinical-stage biotechnology company developing novel therapies to treat mitochondrial diseases and combat age-related decline, today announced that it has been granted two new U.S. patents that further expand and strengthen its global ...

Data Show Strong Functional and Pain Improvements Supported by Excellent Safety ProfilePHOENIX, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage biotechnology company advancing regenerative medicine solutions, today announced positive interim 180-day follow-up data from its FDA-cleared ADAPT clinical trial evaluating CELZ-201 (Olastrocel), the Company’s proprietary perinatal tissue-derived cell therapy for chr ...

Core Insights - Polyrizon Ltd. is committed to advancing its core intranasal medical pipeline while exploring strategic investment opportunities in sectors such as aviation, AI, and defense [1][2][3] - The company is focusing on high-potential sectors for initial investment efforts, while continuing to develop its medical devices, including products like PL-14 and PL-16 [2][3] - Polyrizon's Board of Directors has approved selective investments aimed at generating near-term revenues and enhancing financial stability, leveraging the company's strong cash position and debt-free balance sheet [3] Company Overview - Polyrizon is a development-stage biotech company specializing in innovative medical device hydrogels delivered as nasal sprays, which create a barrier against viruses and allergens [4] - The proprietary Capture and Contain TM hydrogel technology is designed to function as a "biological mask" in the nasal cavity, with ongoing development to improve bioadhesion and drug delivery [4]

[IMAGES BELOW] 11-month sustained complete resolution of lung metastasis observed in Bria-OTS Phase 1/2a metastatic breast cancer study.No treatment limiting toxicities reported.Patient maintained stable disease at all other evaluable sites. PHILADELPHIA and VANCOUVER, British Columbia, Jan. 13, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer ...

We’re now in double-digit January, and there’s no time of the year when more people are thinking about exercising.Thinking about exercising, of course, does very little. The trick remains actually running, cycling, or doing jumping jacks consistently. But motivation and stick-to-itiveness are tricky, Justin Shields, founder of LA’s Venice Run Club, knows better than most. Starting from zero in the pandemic, Shields has seen his Wednesday summer runs grow to more than 500 people, even hitting a 1,000-runner ...